The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation

Journal of Cellular Biochemistry

Volumn 117, Issue 2, 2016, Pages 426-438

  Meredith, Leslie J ^a   Wang, Chiung Min ^a   Nascimento, Leticia ^a   Liu, Runhua ^b   Wang, Lizhong ^b   Yang, Wei Hsiung ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

FOXP2; SUMOylation; TRANSCRIPTIONAL ACTIVITY

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; LYSINE; MICRORNA 200B; MICRORNA 200C; SUMO 1 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; SUSHI REPEAT CONTAINING PROTEIN; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE ACTIVITY; GENE MUTATION; HUMAN; IN VIVO STUDY; LANGUAGE DEVELOPMENT; MOLECULAR PHYLOGENY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; REPORTER GENE; SPEECH DEVELOPMENT; SUMOYLATION; WILD TYPE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMISTRY; CONSENSUS SEQUENCE; HEK293 CELL LINE; MCF-7 CELL LINE; METABOLISM; MOLECULAR GENETICS; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CONSENSUS SEQUENCE; FORKHEAD TRANSCRIPTION FACTORS; HEK293 CELLS; HUMANS; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN STABILITY; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTIONAL ACTIVATION;

EID: 84957309430     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25288     Document Type: Article

References (50)

1. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH,. 2011. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112: 2296-2306.
2. Belaguli NS, Zhang M, Brunicardi FC, Berger DH,. 2012. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation. PLoS ONE 7: e48019.
3. Bellail AC, Olson JJ, Hao C,. 2014. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression. Nat Commun 5: 4234.
4. Chen S, Yu X, Lei Q, Ma L, Guo D,. 2013. The SUMOylation of zinc-fingers and homeoboxes 1 (ZHX1) by Ubc9 regulates its stability and transcriptional repression activity. J Cell Biochem 114: 2323-2333.
5. Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE,. 2014. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell 15: 762-774.
6. Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM,. 2008. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 134: 304-316.
7. Du JX, Bialkowska AB, McConnell BB, Yang VW,. 2008. SUMOylation regulates nuclear localization of Krüppel-like factor 5. J Biol Chem 283: 31991-32002.
8. Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA,. 2003. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 460: 266-279.
9. Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, Yoshida M,. 2009. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16: 133-140.
10. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A, Sistonen L,. 2006. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 103: 45-50.
11. Hisaoka T, Nakamura Y, Senba E, Morikawa Y,. 2010. The forkhead transcription factors, Foxp1 and Foxp2, identify different subpopulations of projection neurons in the mouse cerebral cortex. Neuroscience 166: 551-563.
12. Hurst JA, Baraitser M, Auger E, Graham F, Norell S,. 1990. An extended family with a dominantly inherited speech disorder. Dev Med Child Neurol 32: 352-355.
13. Kishi A, Nakamura T, Nishio Y, Maegawa H, Kashiwagi A,. 2003. Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am J Physiol Endocrinol Metab 284: E830-E840.
14. Lai CS, Fisher SE, Hurst JA, Levy ER, Hodgson S, Fox M, Jeremiah S, Povey S, Jamison DC, Green ED, Vargha-Khadem F, Monaco AP,. 2000. The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am J Hum Genet 67: 357-368.
15. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP,. 2001. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413: 519-523.
16. Lai CS, Gerrelli D, Monaco AP, Fisher SE, Copp AJ,. 2003. FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder. Brain 126: 2455-2462.
17. Martin S, Wilkinson KA, Nishimune A, Henley JM,. 2007. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 8: 948-959.
18. Nagai S, Davoodi N, Gasser SM,. 2011. Nuclear organization in genome stability: SUMO connections. Cell Res 21: 474-485.
19. Oshima M, Mimura J, Sekine H, Okawa H, Fujii-Kuriyama Y,. 2009. SUMO modification regulates the transcriptional repressor function of aryl hydrocarbon receptor repressor. J Biol Chem 284: 11017-11026.
20. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F,. 2002. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120.
21. Reimers-Kipping S, Hevers W, Pääbo S, Enard W,. 2011. Humanized Foxp2 specifically affects cortico-basal ganglia circuits. Neuroscience 175: 75-84.
22. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT,. 1999. SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
23. Roll P, Vernes SC, Bruneau N, Cillario J, Ponsole-Lenfant M, Massacrier A, Rudolf G, Khalife M, Hirsch E, Fisher SE, Szepetowski P,. 2010. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 19: 4848-4860.
24. Rousso DL, Gaber ZB, Wellik D, Morrisey EE, Novitch BG,. 2008. Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron 59: 226-240.
25. Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A,. 2014. Sumoylation of human argonaute 2 at lysine-402 regulates its stability. PLoS ONE 9: e102957.
26. Schimmel J, Eifler K, Sigursson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD, Francavilla C, Medema RH, Olsen JV, Vertegaal AC,. 2014. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell 53: 1053-1066.
27. Schmidt D, Müller S,. 2002. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 99 (5): 2872-2827.
28. Song GG, Choi SJ, Ji JD, Lee YH,. 2012. Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: A meta-analysis. Hum Immunol 73: 1055-1059.
29. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, Paabo S, Tong H, Chen L,. 2006. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14: 159-166.
30. Stumm L, Burkhardt L, Steurer S, Simon R, Adam M, Becker A, Sauter G, Minner S, Schlomm T, Sirma H, Michl U,. 2013. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. J Clin Pathol 66: 563-568.
31. Sun X, Li J, Dong FN, Dong JT,. 2014. Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells. PLoS ONE 9: e92746.
32. Sutinen P, Rahkama V, Rytinki M, Palvimo JJ,. 2014. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation. Mol Endocrinol 28: 1719-1728.
33. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, Hay RT,. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276: 35368-35374.
34. Truong K, Lee TD, Li B, Chen Y,. 2012. Sumoylation of SAE2C terminus regulates SAE nuclear localization. J Biol Chem 287: 42611-42619.
35. Tsui D, Vessey JP, Tomita H, Kaplan DR, Miller FD,. 2013. FoxP2 regulates neurogenesis during embryonic cortical development. J Neurosci 33: 244-258.
36. Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, Bird LE, Davies KE, Fisher SE,. 2006. Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet 15: 3154-3167.
37. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcõn M, Oliver PL, Davies KE, Geschwind DH, Monaco AP, Fisher SE,. 2008. A functional genetic link between distinct developmental language disorders. N Engl J Med 359: 2337-2345.
38. Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor JM, Ho J, Mombereau C, Brewer A, Lowy E, Nicod J, Groszer M, Baban D, Sahgal N, Cazier JB, Ragoussis J, Davies KE, Geschwind DH, Fisher SE,. 2011. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet 7: e1002145.
39. Walker RM, Hill AE, Newman AC, Hamilton G, Torrance HS, Anderson SM, Ogawa F, Derizioti P, Nicod J, Vernes SC, Fisher SE, Thomson PA, Porteous DJ, Evans KL,. 2012. The DISC1 promoter: characterization and regulation by FOXP2. Hum Mol Genet 21: 2862-2872.
40. Wang CM, Liu R, Wang L, Yang WH,. 2013. Acidic residue Glu199 increases SUMOylation level of nuclear hormone receptor NR5A1. Int J Mol Sci 14: 22331-22345.
41. Wang CM, Liu R, Wang L, Nascimento L, Brennan VC, Yang WH,. 2014a. SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells. Int J Mol Sci 15: 10233-10251.
42. Wang L, Wansleeben C, Zhao S, Miao P, Paschen W, Yang W,. 2014b. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development. EMBO Rep 15: 878-885.
43. Wilkinson KA, Henley JM,. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 428: 133-145.
44. Yan Q, Gong L, Deng M, Zhang L, Sun S, Liu J, Ma H, Yuan D, Chen PC, Hu X, Liu J, Qin J, Xiao L, Huang XQ, Zhang J, Li DW,. 2010. Sumoylation activates the transcriptional activity of Pax-6, an important transcription factor for eye and brain development. Proc Natl Acad Sci USA 107: 21034-21039.
45. Yang SH, Galanis A, Witty J, Sharrocks AD,. 2006. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25: 5083-5093.
46. Yang WH, Heaton JH, Brevig H, Mukherjee S, Iñiguez-Lluhí JA, Hammer GD,. 2009. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Mol Cell Biol 29: 613-625.
47. Yang Z, Hikosaka K, Sharkar MT, Tamakoshi T, Chandra A, Wang B, Itakura T, Xue X, Uezato T, Kimura W, Miura N,. 2010. The mouse forkhead gene Foxp2 modulates expression of the lung genes. Life Sci 87: 17-25.
48. Ying H, Lyu J, Ying T, Li J, Jin S, Shao J, Wang L, Xu H,. 2014. Risk miRNA screening of ovarian cancer based on miRNA functional synergistic network. J Ovarian Res 7: 9.
49. Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP,. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748-2752.
50. Zhou B, Zhong Q, Minoo P, Li C, Ann DK, Frenkel B, Morrisey EE, Crandall ED, Borok Z,. 2008. Foxp2 inhibits Nkx2.1-mediated transcription of SP-C via interactions with the Nkx2.1 homeodomain. Am J Respir Cell Mol Biol 38: 750-758.